Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091)
Author:
Funder
European Organisation for Research and Treatment of Cancer
Roche
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference28 articles.
1. Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial;Van den Bent;Lancet Oncol,2018
2. Health-related quality of life in patients with brain tumors: limitations and additional outcome measures;Dirven;Curr Neurol Neurosci Rep,2013
3. Review on quality of life issues in patients with primary brain tumors;Taphoorn;Oncologist,2010
4. Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas;Reijneveld;Neurology,2001
5. Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study;Reijneveld;Lancet Oncol,2016
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nanomedicine facilitated cell signaling blockade: difficulties and strategies to overcome glioblastoma;Journal of Materials Chemistry B;2024
2. The role of angiogenic growth factors in the immune microenvironment of glioma;Frontiers in Oncology;2023-09-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3